ArticleFrontiers in public health2022

Corrigendum: Cost-effectiveness of avelumab maintenance therapy plus best supportive care vs. best supportive care alone for advanced or metastatic urothelial carcinoma.

Qian Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.